ApaTech is Europe’s Fastest Growing Lifescience Company
orthobiologics company, was named
Biotech/Pharmaceutical/Medical Technology/Equipment company in the Deloitte
2009 Technology Fast 500 for EMEA (
This annual ranking is based on a companies’ five-year revenue growth,
for which ApaTech has achieved a rate of 8,318% over this period. This
achievement places ApaTech 9th overall in the ranking that includes the
fastest growing public and private technology, media, telecommunications,
life sciences and green technology companies from 26 countries in EMEA.
great product based on great technology, with a great team behind it can
achieve incredible results. The determination to succeed is embedded in the
fabric of our business and the people that work here; their passion and
ambition are the reason for our success.”
“Because Deloitte Technology Fast 500 EMEA measures sustained revenue
growth over five years, being one of the 500 fastest growing technology
companies in EMEA is an impressive achievement,” said
in charge of Deloitte’s Technology Fast 500 EMEA program. “ApaTech deserves a
lot of credit for its remarkable growth.”
The Deloitte Technology Fast 500 is the most objective industry-ranking
standard to focus on the technology sector. Entrants to the ranking must have
been in business at least five years and have had base-year operating
revenues of at least
least
ApaTech is the developer and manufacturer of Actifuse(R), a unique fully
synthetic silicate substituted calcium phosphate bone graft material for
orthopaedic, spinal, dental and craniomaxillofacial applications. The
Actifuse scaffold mimics the body’s natural bony structure and accelerates
the growth of high quality bone. Actifuse is being used by surgeons in more
than 30 countries around the world.
Notes to Editors:
About ApaTech(R)
ApaTech is a company specializing in synthetic bone repair materials for
orthopedic and dental applications. With operations in
Foxborough,
leader in research and development of bone graft technologies. The company
has enjoyed strong commercial success globally with products sold in 33
countries.
ApaTech has developed and commercialized a novel silicate substituted
calcium phosphate bone graft material, Actifuse(R). Actifuse is the first of
a new class of synthetic bone graft materials that combine osteoconductive,
osteostimulatory and bioactive qualities resulting in accelerated bone
growth. The Actifuse technology platform exemplifies the Company’s leadership
in applying the science of silicon to bone graft technologies. ApaTech is
backed by international investors Encore Ventures and Healthcor and following
its formation in 2001, the Company has raised more than
ApaTech is committed to delivering shareholder value by using its
scientific leadership to deliver targeted solutions to physicians, allowing
them to significantly improve patient outcomes.
ApaTech has received several corporate business and research awards,
including the Frost & Sullivan ’2009 North American Device Biologics Company
of the Year’ as a result of its success in the US orthobiologics market. More
recently, ApaTech was awarded 3rd place in the UK Deloitte Technology Fast 50
(2009), in addition to being recognized as
technology company 3 years running in 2009, 2008 and 2007 by the Sunday Times
Fast Track 100 fastest growing private technology companies review.
More details can be found at http://www.apatech.com
About Deloitte
“Deloitte” is the brand under which tens of thousands of dedicated
professionals in independent firms throughout the world collaborate to
provide audit, consulting, financial advisory, risk management and tax
services to selected clients. These firms are members of Deloitte Touche
Tohmatsu, a Swiss Verein (“DTT”). Each member firm provides services in a
particular geographic area and is subject to the laws and professional
regulations of the particular country or countries in which it operates. DTT
helps coordinate the activities of the member firms but does not itself
provide services to clients. DTT and the member firms are separate and
distinct legal entities, which cannot obligate the other entities. DTT and
each DTT member firm are only liable for their own acts or omissions, and not
those of each other. Each DTT Member Firm is structured differently in
accordance with national laws, regulations, customary practice and other
factors, and may secure the provision of professional services in their
territories through subsidiaries, affiliates and/or other entities.
Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss
Verein, and its network of member firms, each of which is a legally separate
and independent entity. Please see http://www.deloitte.com/about for a
detailed description of the legal structure of Deloitte Touche Tohmatsu and
its Member Firms.
(c) 2009 Deloitte Touche Tohmatsu. All rights reserved.
Further Information:
ApaTech
Simon Cartmell, CEO +44-20-8731-4640
simon.cartmell@apatech.com
http://www.apatech.com
Waughton
Robin Hepburn +44-20-7796-9999
rhepburn@waughton.com
http://www.waughton.com
SOURCE ApaTech